‘Viral load’ is the amount of HIV in your blood. You’ll have this tested regularly as part of your care to manage the virus. A viral load test on someone’s blood gives a good idea of how much HIV is in their semen or vaginal fluid too.
A person with HIV who is taking treatment and has an undetectable viral load cannot pass on HIV - although it can take up to six months on treatment to become undetectable.
Yes. If you’re taking HIV medication and have an undetectable viral load, you can’t pass on HIV.
A large study called PARTNER looked at 888 gay and straight couples (and 58,000 sex acts) where one partner was HIV positive and one was HIV negative. Results found that where the HIV positive partner was on treatment had an undetectable viral load, there were no cases of HIV transmission whether they had anal or vaginal sex without a condom.
The PARTNER study looked at couples where the HIV positive partner had a viral load below 200. An undetectable viral load is classed as being below 20 copies/ml.
The Partners PrEP study looked at the risk of transmission in the time it took for the HIV positive partner to achieve an undetectable viral load. In most cases (84.8%) this happened within six months and there were no infections once someone had been on treatment for six months or more.
The result is measured in copies (of the virus) per millilitre (ml) of blood and it can range from over 1,000,000/ml to fewer than 20/ml. Your doctor is likely to describe your viral load using just the number. For somebody not on HIV treatment, a viral load above 100,000 is considered high and one below 10,000 is considered low.
The aim of effective treatment is to reduce your viral load to undetectable levels (which can take up to six months), so that you can't pass on HIV.
An undetectable viral load doesn't mean there's no HIV present - HIV is still there but in levels too low for the laboratory test to pick up. Different laboratories may have different cut off points when classifying undetectable viral load, but most clinics in the UK classify undetectable as being below 20 copies/ml.
National guidelines recommend that everyone with HIV starts treatment right away.
This recommendation reflects the findings of the START study. It found that people who delayed treatment until their CD4 count dropped to 350 - which is when people were previously advised to start treatment - had a significantly higher chance of developing AIDS-related illnesses such as cancers.
Starting treatment will protect your health and reduce your viral load to undetectable levels. Early diagnosis and treatment means people living with HIV can expect to live as long as the general population.
For further information on CD4 count and viral load, see the Viral load and CD4 count page in our Simple Science section.
Next: Public sex environments ››
‹‹ Back to: Multiple sex partners
(1 vote cast)
Please log in
or register to vote.
to add this article to My favourites.
Adding an article to My favourites will allow you to easily come back to it later or print it.
You will need to be logged in before you can leave a comment.
Please log in using the form on the top right of the page or register.
This article was last reviewed on
by Anna Peters
Date due for the next review: 25/2/2020
Content Author: Richard Scholey
Current Owner: Health Promotion
HIV Transmission Risk Persists During the First 6 Months of Antiretroviral Therapy, Mujugira A1, Celum C, Coombs RW, Campbell JD, Ndase P, Ronald A, Were E, Bukusi EA, Mugo N, Kiarie J, Baeten JM; Partners PrEP Study Team
National Center for Biotechnology Information
US National Library of Medicine
2016 Aug 15;72(5):579-84. doi: 10.1097/QAI.0000000000001019
HIV treatment as prevention and HPTN 052, Cohen MS1, McCauley M, Gamble TR
National Center for Boiotechnology Information
US National Library of Medicine
Oral late breaker abstract 153LB in HIV transmission risk through condomless sex if HIV+ partner on suppressive ART: PARTNER Study, Rodger A et al., 21st Conference on Retroviruses and Opportunistic Infections, 3-6 March 2014, Boston.
Questions and Answers on the Use of HIV Medications to Help Prevent the Transmission of HIV, Centers for Disease Control and Prevention (2010)
HIV Viral Load Testing Canadian AIDS Treatment Information Exchange (Public Health Agency of Canada) (2007)
aidsmap: Viral load, NAM, March 2014
Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy, Journal of the American Medical Association: Alison J. Rodger, MD; Valentina Cambiano, PhD; Tina Bruun, RN; Pietro Vernazza, MD; Simon Collins; Jan van Lunzen, PhD; Giulio Maria Corbelli; Vicente Estrada, MD; Anna Maria Geretti, MD; Apostolos Beloukas, PhD; David Asboe, FRCP; Pompeyo Viciana, MD1; Félix Gutiérrez, MD; Bonaventura Clotet, PhD; Christian Pradier, MD; Jan Gerstoft, MD; Rainer Weber, MD; Katarina Westling, MD; Gilles Wandeler, MD; Jan M. Prins, PhD; Armin Rieger, MD; Marcel Stoeckle, MD; Tim Kümmerle, PhD; Teresa Bini, MD; Adriana Ammassari, MD; Richard Gilson, MD; Ivanka Krznaric, PhD; Matti Ristola, PhD; Robert Zangerle, MD; Pia Handberg, RN; Antonio Antela, PhD; Sris Allan, FRCP; Andrew N. Phillips, PhD; Jens Lundgren, MD
JAMA. 2016;316(2):171-181. doi:10.1001/jama.2016.5148
Viral load, Michael Carter, Greta Hughson, NAM, Aidsmap, March 2014
More confidence on zero risk: still no transmissions seen from people with an undetectable viral load in PARTNER study, Gus Cairns, NAM, Aidsmap, July 2016
Open your eyes to STIs, NHS Choices, Nov 2015
When sex goes wrong, NHS Choices, Nov 2015
START trial finds that early treatment improves outcomes for people with HIV, Gus Cairns, NAM, Aidsmap, May 2015
New British guidelines recommend treatment for everyone living with HIV, Keith Alcorn, NAM Aidsmap, June 2015
START trial provides definitive evidence of the benefits of early HIV treatment, Liz Highleyman, Produced in collaboration with hivandhepatitis.com, NAM Aidsmap, July 2015
BHIVA guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015, Writing Group: Duncan Churchill Chair Laura Waters Vice Chair N Ahmed, B Angus, M Boffito, M Bower, D Dunn, S Edwards, C Emerson, S Fidler, †M Fisher, R Horne, S Khoo, C Leen, N Mackie, N Marshall, F Monteiro, M Nelson, C Orkin, A Palfreeman, S Pett, A Phillips, F Post, A Pozniak, I Reeves, C Sabin, R Trevelion, J Walsh, E Wilkins, I Williams, A Winston
Viral load, NAM, Aidsmap, July 2012
What is the life expectancy for someone with HIV?, NHS Choices, May 2015
Various people talk about their experiences of living with HIV.
CAB - Citizens Advice Bureau
HIV Drug Interactions
George House Trust
Equality and Human Rights Commission
Copyright 2017 © Terrence Higgins Trust is a registered charity in England and Wales (reg. no. 288527)
Company reg. no. 1778149 and a registered charity in Scotland (reg. no. SC039986). Registered office: 314-320 Gray's Inn Road, London, WC1X 8DP.